
Opinion|Videos|January 10, 2025
Tailored Support: The Role of Industry-Provided Services in Lymphoma Care
Panelists discuss how they assess the individual support needs of patients diagnosed with diffuse large B-cell lymphoma or follicular lymphoma and describe an ideal model for industry-provided support services for these patients.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- How do you assess the individual support needs of each patient when they are diagnosed with diffuse large B-cell lymphoma (DLBCL) or follicular lymphoma (FL)?
- In a perfect world, describe what industry-provided support services look like for patients diagnosed with DLBCL and FL.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
'Tis the Season: SABCS 2025 to Highlight Latest Advances Across the Breast Cancer Continuum
2
Once-Monthly Maridebart Cafraglutide Shows Up to 16% Weight Loss
3
Azacitidine/Venetoclax Combo Data Challenge Chemo in Fit Patients With AML
4
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
5












































